Prospective monitoring N-terminal pro-brain natriuretic peptide during natural progression of atherosclerotic renal artery stenosis in elderly

Archives of Gerontology and Geriatrics

Volumn 56, Issue 2, 2013, Pages 395-399

  Zhu, Qiwei ^a   An, Ningyu ^a   Bai, Yongyi ^a   Zhu, Ning ^a   Li, Meihua ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Follow up studies; N terminal pro brain natriuretic peptide; Occlusion; Renal artery

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADVERSE OUTCOME; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE ASSOCIATION; ELDERLY CARE; FOLLOW UP; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGE FACTORS; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RENAL ARTERY OBSTRUCTION; RISK FACTORS;

EID: 84872498875     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2012.09.005     Document Type: Article

References (28)

1. De Mast Q., Beutler J.J. The prevalence of atherosclerotic renal artery stenosis in risk groups: A systematic literature review. Journal of Hypertension 2009, 27:1333-1340.
2. DeForrest J.M., Knappenberger R.C., Antonaccio M.J., Ferrone R.A., Creekmore J.S. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat. American Journal of Cardiology 1982, 49:1515-1517.
3. Edwards M.S., Craven T.E., Burke G.L., Dean R.H., Hansen K.J. Renovascular disease and the risk of adverse coronary events in the elderly: A prospective. Population-based study. Archives of Internal Medicine 2005, 165:207-213.
4. Heringlake M., Heide C., Bahlmann L., Eichler W., Pagel H., Schmucker P., et al. Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. Journal of Applied Physiology 2004, 97:173-179.
5. Januzzi J.L., Chen-Tournoux A.A., Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. American Journal of Cardiology 2008, 101:29-38.
6. Kalra P.A., Guo H., Gilbertson D.T., Liu J., Chen S.C., Ishani A., et al. Atherosclerotic renovascular disease in the United States. Kidney International 2010, 77:37-43.
7. Kumar S.K., MacGinley R., Mantha M., Mount P., Roberts M., Mangos G., et al. The CARI guidelines. Natural history and progression of atherosclerotic renal vascular stenosis. Nephrology (Carlton) 2010, 15(Suppl. 1):S204-S209.
8. Lai K.N., Leung J.C., Yandle T.G., Fisher S., Nicholls M.G. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. Journal of Hypertension 1999, 17:575-583.
9. Lappe R.W., Todt J.A., Wendt R.L. Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats. Circulation Research 1987, 61:134-140.
10. Levey A.S., Eckardt K.U., Tsukamoto Y., Levin A., Coresh J., Rossert J., et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International 2005, 67:2089-2100.
11. Maisel A.S., Nakao K., Ponikowski P., Peacock W.F., Yoshimura M., Suzuki T., et al. Japanese-Western consensus meeting on biomarkers. International Heart Journal 2011, 52:253-265.
12. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension 1991, 17:707-719.
13. Ma Y.C., Zuo L., Chen J.H., Luo Q., Yu X.Q., Li Y., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology 2006, 17:2937-2944.
14. Mistry S.K., Hawksworth G.M., Struthers A.D., McLay J.S. Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells. Journal of Hypertension 2001, 19:255-262.
15. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., et al. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriureticpeptide and brain natriuretic peptide. Journal of Clinical Investigation 1991, 87:1402-1412.
16. Navasiolava N.M., Pajot A., Gallois Y., Pastushkova LKh., Kulchitsky V.A., Gauquelin-Koch G., et al. NT-ProBNP levels, water and sodium homeostasis in healthy men: Effects of 7 days of dry immersion. European Journal of Applied Physiology 2011, 111:2229-2237.
17. Nonoguchi H., Tomita K., Marumo F. Effects of atrial natriuretic peptide and vasopressin on chloride transport in long-and short-looped medullary thick ascending limbs. Journal of Clinical Investigation 1992, 90:349-357.
18. Nishimura M., Milsted A., Bloch C.H., Brosnihan K.B., Ferrario C.M. Tissue renin-angiotensin systems in renal hypertension. Hypertension 1992, 20:158-167.
19. Pearce J.D., Craven B.L., Craven T.E., Piercy K.T., Stafford J.M., Edwards M.S., et al. Progression of atherosclerotic renovascular disease: A prospective population-based study. Journal of Vascular Surgery 2006, 44:955-963.
20. Pfisterer M., Buser P., Rickli H., Gutmann M., Erne P., Rickenbacher P., et al. BNP-guided vs symptom-guided heart failure therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients with Congestive Heart Failure (TIME-CHF) randomized trial. The Journal of the American Medical Association 2009, 301:383-392.
21. Pillay W.R., Kan Y.M., Crinnion J.N., Wolfe J.H. Joint Vascular Research Group. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease. British Journal of Surgery 2002, 89:737-740.
22. Prnjavorac B., Abduzaimović K., Jukić J., Sejdinović R., Mujarić E., Irejiz N., et al. Use of amino-terminal pro-B type natriuretic peptide as the parameter for long-term monitoring of water overload in patient with chronic kidney diseases. Med Glas Ljek komore Zenicko-doboj kantona 2011, 8:116-120.
23. Rundback J.H., Sacks D., Kent C., Cooper C., Jones D., Murphy T., et al. Guidelines for reporting renal artery revascularization in clinical trials. Circulation 2002, 106:1572-1585.
24. Staub D., Zeller T., Trenk D., Maushart C., Uthoff H., Breidthardt T., et al. Use of B-type natriuretic peptide to predict blood pressure improvement after percutaneous revascularisation for renal artery stenosis. European Journal of Vascular Surgery 2010, 40:599-607.
25. Totsune K., Takahashi K., Murakami O., Satoh F., Sone M., Saito T., et al. Natriuretic peptides in the human kidney. Hypertension 1994, 24:758-762.
26. Van Biesen W., Williams J.D., Covic A.C., Fan S., Claes K., Lichodziejewska-Niemierko M., et al. Fluid status in peritoneal dialysis patients: The European Body Composition Monitoring (EuroBCM) study cohort. PLoS One 2011, 6:e17148. doi:10.1371/journal.pone.0017148.
27. Zhang Y., Ge J.B., Qian J.Y., Ye Z.B. Prevalence and risk factors of atherosclerotic renal artery stenosis in 1200 Chinese patients undergoing coronary angiography. Nephron Clinical Practice 2006, 104:c185-c192.
28. Zuo L., Ma Y.C., Zhou Y.H., Wang M., Xu G.B., Wang H.Y. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. American Journal of Kidney Diseases 2005, 45:463-472.